Tech Company Financing Transactions
N-Power Medicine Funding Round
On 7/1/2024, N-Power Medicine secured Series B investment from Merck Global Health Innovation Fund and private investors.
Transaction Overview
Company Name
Announced On
7/1/2024
Transaction Type
Venture Equity
Amount
Unknown
Round
Series B
Investors
Merck Global Health Innovation Fund (Lead Investor)
Proceeds Purpose
The company intends to use the funds for the expansion of its network of oncology clinics and biopharmaceutical company collaborations leveraging its platform for integrating clinical research into everyday patient care.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
2221 Broadway
Redwood City, CA 94063
USA
Redwood City, CA 94063
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
N-Power and its purpose-built clinical research platform empowers oncology practices and biopharma companies to accelerate drug development and make better-informed decisions. N-Power catalyzes clinical research by equipping oncology practices with the N-Power Platform and connecting them to industry research sponsors.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Mark Lee
Co-Founder
Christer Svedman
VP - Administration
Maria Ferrari
VP - Bus. Development
Dan Schneider
VP - General Counsel
Ruchika Kumar
VP - Regulatory Affairs
Emily Luvison
Browse more venture capital transactions:
Prev: 7/1/2024: Eve Air Mobility venture capital transaction
Next: 7/1/2024: Barn2Door venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record funding rounds that are announced publicly. VC transactions on this site are sourced from a variety of public sources. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs